Target intelligence / Profile preview

RNA, U7 small nuclear 52 pseudogene (RNU7-52P)

Target
RNU7-52P
Molecular classification
Pseudogene, small nuclear RNA (snRNA) pseudogene, non-coding RNA, Other
01

Overview

**RNA, U7 small nuclear 52 pseudogene** (RNU7-52P) is classified as a pseudogene of the family of small nuclear RNAs (snRNAs). In general, U7 small nuclear RNA (snRNA) is a functional non-coding RNA required for the 3' end processing of histone pre-mRNA as part of the U7 small nuclear ribonucleoprotein (snRNP) complex[2][5]. The “52 pseudogene” version, RNU7-52P, is not believed to encode a functional RNA molecule and thus does not contribute directly to RNA processing or disease; it is considered a nonfunctional, genomic relic derived from the ancestral active U7 snRNA gene[8]. There is no evidence that RNU7-52P is a therapeutic target, is druggable, or is involved in any disease directly, nor is it referenced as a diagnostic or prognostic biomarker[8]. Additional context: Pseudogenes like RNU7-52P generally do not produce an active product and are not considered targets for drugs or therapies. Occasionally, pseudogenes can have regulatory roles, but no such function has been described for RNU7-52P[8]. Orthologous functional genes, such as RNU7-1 or its product U7 snRNA, have established importance in gene expression regulation, specifically histone mRNA 3' end processing, but this does not apply to the pseudogene variant[1][6][8].

Other names
U7.52RNU7-52PRNA, U7 small nuclear 52 pseudogene

Beyond the preview

Go deeper on RNA, U7 small nuclear 52 pseudogene (RNU7-52P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 small nuclear 52 pseudogene (RNU7-52P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call